A5058427085- Vaccine Coverage and Hesitancy
- Migration, Health and Trauma
- Hepatitis Viruses Studies and Epidemiology
- SARS-CoV-2 and COVID-19 Research
- Tuberculosis Research and Epidemiology
- Malaria Research and Control
- Global Health Workforce Issues
- Virology and Viral Diseases
- Mosquito-borne diseases and control
- Hepatitis B Virus Studies
- COVID-19 and healthcare impacts
- Global Maternal and Child Health
- Influenza Virus Research Studies
- COVID-19 epidemiological studies
- Healthcare Systems and Reforms
- Congenital Anomalies and Fetal Surgery
- Hepatitis C virus research
- Health and Conflict Studies
- Travel-related health issues
- Infant Nutrition and Health
- Healthcare Systems and Challenges
- Misinformation and Its Impacts
- Hate Speech and Cyberbullying Detection
- Parasites and Host Interactions
- Migration and Labor Dynamics
St George's, University of London
2020-2025
Faculty of Public Health
2020-2024
London School of Hygiene & Tropical Medicine
2020-2024
Edward Via College of Osteopathic Medicine
2024
City St George's, University of London
2021-2024
Hamilton Medical Center
2024
Swiss Tropical and Public Health Institute
2019-2023
University of Basel
2019-2023
Institute of Infection and Immunity
2021-2022
University of London
2021
Migrants have been disproportionately impacted by COVID-19 and emerging evidence suggests they may face barriers to vaccination. Participatory approaches engagement strategies are urgently needed strengthen uptake, alongside innovative delivery mechanisms sharing of best practice, ensure migrants better consider within countries’ existing vaccine priority structures.
COVID-19 has led to big changes in UK primary care, including rapid digitalisation, with unknown impact on migrant groups.To understand the pandemic's recently-arrived migrants and their access health implications for vaccine roll-out.Qualitative study involving semi-structured interviews care professionals (PCPs) urban, suburban, rural settings across England.Sixty-four PCPs administrative staff, 17 were recruited using purposive, convenience, snowball sampling. In-depth, conducted by...
Early evidence confirms lower COVID-19 vaccine uptake in established ethnic minority populations, yet there has been little focus on understanding hesitancy and barriers to vaccination migrants. Growing populations of precarious migrants (including undocumented migrants, asylum seekers refugees) the UK Europe are considered be under-immunised groups may excluded from health systems, is known about their views vaccines specifically, which essential identify key solutions action points...
ABSTRACT Plasmodium falciparum sporozoite (PfSPZ) Vaccine (radiation-attenuated, aseptic, purified, cryopreserved PfSPZ) and PfSPZ-CVac (infectious, PfSPZ administered to subjects taking weekly chloroquine chemoprophylaxis) have shown vaccine efficacies (VEs) of 100% against homologous controlled human malaria infection (CHMI) in nonimmune adults. sporozoite-CVac has never been assessed CHMI African vaccinees. We the safety, immunogenicity, VE three doses 2.7 × 10 6 at 8-week intervals 1.0 5...
Some refugee and migrant populations globally showed lower uptake of COVID-19 vaccines are also considered to be an under-immunized group for routine vaccinations. These communities may experience a range barriers vaccination systems, yet there is need better explore drivers under-immunization vaccine hesitancy in these mobile groups.
Abstract Background Migrants in the UK and Europe face vulnerability to vaccine-preventable diseases (VPDs) due missed childhood vaccines doses marginalisation from health systems. Ensuring migrants receive catch-up vaccinations, including MMR, Td/IPV, MenACWY, HPV, is essential align them with European vaccination schedules ultimately reduce morbidity mortality. However, recent evidence highlights poor awareness implementation of guidelines by primary care staff, requiring novel approaches...
Introduction The Middle East and North Africa (MENA) region is characterised by major health disparities complex migration flows. Yet, because of a lack epidemiological data, there an urgent need to strengthen routine data collection around migrant define key indicators towards monitoring. To address this problem, we aim design pilot test the Migrant Health Country Profile tool (MHCP-t) which can collate country-level policies healthcare provision. Methods analysis MHCP-t development...
Plasmodium falciparum sporozoite (PfSPZ) Vaccine is composed of radiation-attenuated, aseptic, purified cryopreserved PfSPZ. Multiple clinical trials empirically assessing two to six doses have shown multi-dose priming (two four the first week) be optimal for protection in both 4- and 16-week regimens. In this randomized, double-blind, normal saline (NS) placebo-controlled trial, groups (G) 18- 32-year-old Equatoguineans received regimens with or without a delayed final dose at 4 16 weeks....
WHO's new Immunization Agenda 2030 places a focus on ensuring migrants and other marginalised groups are offered catch-up vaccinations across the life-course. Yet, it is not known to what extent specific groups, such as refugees, immunised according host country schedules, implications for policy practice. We aimed assess immunisation coverage of UK-bound refugees undergoing International Organization Migration (IOM) health assessments through UK resettlement schemes, calculate risk factors...
Explore primary care professionals' views around barriers/facilitators to catch-up vaccination in adult migrants (foreign-born; over 18 years of age) with incomplete/uncertain status and for routine vaccines inform development interventions improve vaccine uptake coverage. Qualitative interview study purposive sampling thematic analysis. UK care. 64 professionals (PCPs): 48 clinical-staff including general practitioners, practice nurses healthcare assistants; 16 administrative-staff managers...
Abstract Introduction Disparities in the uptake of routine and COVID‐19 vaccinations have been observed migrant populations, attributed to issues mistrust, access low vaccine confidence. Participatory research approaches behaviour change theory hold potential for developing tailored vaccination interventions that address these complex barriers partnership with communities should be explored further. Methods This study used a theory‐informed, community‐based participatory approach co‐design...
Migrants in Europe face a disproportionate burden of undiagnosed infection, including tuberculosis, blood-borne viruses, and parasitic infections many belong to an under-immunised group. The European Centre for Disease Control (ECDC) has called innovative strategies deliver integrated multi-disease screening migrants within primary care, yet this is poorly implemented the UK. We did in-depth qualitative study understand current practice, barriers solutions infectious disease seek feedback on...
Abstract The rapid and accurate diagnosis of Plasmodium falciparum malaria infection is an essential factor in control. Currently, the field depends heavily on using diagnostic tests (RDTs) many which detect circulating parasite-derived histidine-rich protein 2 antigen (PfHRP2) capillary blood. P . strains lacking PfHRP2, due to pfhrp2 gene deletions, are emerging threat control programs. novel assay described here, named qHRP2/3-del, well suited for high-throughput screening isolates...